Practical AI-Assisted Medical Writing for Media & Communications

Target audience

Who this is for

Designed for pharma and biotech communications teams, hospital PR, medical writers, regulatory liaisons, patient advocates, and agencies supporting life-sciences announcements. Use this workflow when accuracy, traceability and regulatory sensitivity matter.

• Pharma/biotech communications and corporate PR
• Hospital and health system communications teams
• Medical writers, scientific communicators and medical affairs
• Patient advocacy groups and clinical trial communications managers
• Regulatory and compliance reviewers supporting external messaging

Practical outputs

Common use cases

From embargoed topline results to patient-friendly summaries and rapid holding statements, these outputs are structured to reduce back-and-forth and to make reviewer sign-off straightforward.

• Press releases and media advisories for trial results or product milestones
• Patient-facing lay summaries and safety communications
• HCP briefs and slide bullets for scientific presentations
• Media Q&A kits and reporter-ready reference lists
• Crisis and embargo-ready holding statements with clinical/legal flags
• Localized communications for US, EU/UK and APAC regulatory contexts

From brief to publish-ready copy

How it works — practical workflow

Start with a structured briefing (trial name, topline outcome, source IDs). Choose a media-focused template, attach source identifiers (PubMed ID, ClinicalTrials.gov NCT), generate audience variants, and move content through a controlled reviewer workflow that highlights sentences requiring clinical or legal sign-off.

• Step 1 — Brief: paste the study abstract, protocol highlights, and source IDs.
• Step 2 — Choose template: press release, patient summary, HCP brief, Q&A or crisis statement.
• Step 3 — Generate variants: single briefing produces HCP, patient, and media drafts.
• Step 4 — Review: follow the structured reviewer checklist and resolve flagged items.
• Step 5 — Export: export press-ready copy and social assets for distribution.

Copy-ready prompt clusters

Prompt templates you can use

Below are practical prompts to paste into an AI drafting tool or use as templates when briefing writers. Each prompt is designed to preserve scientific nuance and tie outputs back to verifiable sources.

• Press release & media advisory: “Write a 300–450 word press release announcing topline results for {trial_name}. Include a 20-word lede, one-paragraph background, primary endpoint summary (plain language), three key quotes (CEO, lead investigator, patient advocate), and a 5-bullet takeaway for reporters. Add a Cite: list with PubMed IDs or ClinicalTrials.gov link.”
• Patient-facing summary: “Convert the following abstract into a 150–200 word patient-friendly summary for {condition}. Keep reading level around 8th grade, avoid medical jargon, explain benefits and risks, and include one suggested call-to-action for patients.”
• HCP summary & slide bullets: “Produce a concise 150-word HCP brief highlighting study design, primary/secondary endpoints, effect sizes (as reported), safety signals, and three suggested slides for a clinical overview presentation.”
• Crisis statement & rapid response: “Draft a 75–120 word holding statement for an adverse event under investigation. Tone: neutral, timely, and empathetic. Include next steps and contact info for media — mark sentences requiring legal or clinical review.”

Prepared outputs

Templates & export formats

Choose a template to generate reviewer-ready outputs. Templates include built-in guidance for what must be verified by clinicians, legal, or regulatory affairs before publication.

Trusted medical sources

Source ecosystem & verification

Drafts created from journal abstracts, registry entries and regulatory summaries should always include source identifiers for verification. Use primary sources for clinical claims and avoid secondary summaries when precision is required.

• Primary sources: PubMed / MEDLINE abstracts, PubMed Central open-access full texts
• Registry data: ClinicalTrials.gov entries and results summaries
• Regulatory references: FDA labeling and safety communications, EMA public assessment reports
• Guidance and context: WHO advisories and major medical journals (NEJM, Lancet, JAMA)
• Media framing: trusted medical news outlets for contextual headlines (use only for framing, not clinical claims)

Reduce approval cycles

Reviewer workflow & checklist

Use a structured reviewer workflow to ensure accuracy and regulatory compliance. Each generated draft should travel with a checklist that identifies which sentences require which sign-offs.

• Checklist items: source verification, numerical result confirmation, safety/signal language, region-specific terminology, embargo handling
• Flagging: mark lines that need clinical, legal, or regulatory review before publication
• Audit trail: keep the original brief, source IDs and reviewer notes together for post-publication traceability

Region-specific guidance

Localization & regulatory sensitivity

Create separate plain-language conversions or localize terminology for US, EU/UK and APAC readers. Highlight terms or claims that should be confirmed with regulatory affairs before regional distribution.

• Produce region-specific variants and list terms to confirm with regulatory affairs
• Adjust safety phrasing and legal disclosures to local norms
• Maintain consistent key messages across localized outputs

Get started quickly

Implementation steps

A simple five-step implementation plan for communications teams.

• 1. Prepare a structured briefing with source IDs and desired audience.
• 2. Select one of the media-focused templates and attach sources (PMID, DOI, NCT).
• 3. Generate audience variants and run an internal accuracy pass with subject-matter experts.
• 4. Route drafts through the reviewer checklist (clinical, legal, regulatory).
• 5. Export approved copy in distribution-ready formats and retain the audit trail.